CrossrefInfokarte
Survival Outcomes Post-secondary Cytoreduction in Peritoneal Metastatic Cases from Ovarian Cancer: A Single Institute Study
Anticancer Research · 2025-10 · 45 (10) · 4281-4293
DOI: 10.21873/anticanres.17779 ↗Abstract
Kein Abstract verfügbar.
EUVIMED